NCT04377646 - A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers | Biotech Hunter

Enrollment

660

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

May 24, 2020

Study Completion Date

July 31, 2020

Conditions

Sars-CoV2COVID19

Interventions

DRUG

Hydroxychloroquine

400 mg at day 1 and day 2, then 400 mg weekly up to 2 months

DRUG

Hydroxychloroquine (placebo)

1 pill at day 1 and day 2, then 1 pill weekly up to 2 months

DRUG

Zinc

15 mg per day up to 2 months

DRUG

Zinc (Placebo)

1 pill per day up to 2 months

Trial Locations (1)

Military Hospital of Tunis, Tunis